FDA Investigator Laura L Van Wagenen
Laura L Van Wagenen has inspections in 1 countries as of 20 Oct 2023. Laura L Van Wagenen has collaborated with a combined 1430 experts on various inspections, contributing to compliance and improvement across diverse sectors.
Investigator Details
Number of Inspected Sites:
23
Last Inspection Date:
20 Oct 2023
Investigator Role:
FDA Investigator
Redica ID:
Country:
United States of America
Co-Investigator(s):
Alan M Barker,
Andrea J Schmidt,
Andrew M Kolenc,
Brandon K Lawson,
Brittany R Laymon,
Bruce W Benware,
Carla R Hinz,
Carrie E Jolly,
Christine L Williams,
Daniel Pst Laurent,
Daniel T Smith,
David A Gonzalez,
David C Thomas,
Debra L Curtis,
Donald R Hawn,
Duc Minh H Nguyen,
Edith M Gonzalez,
Elisa J Beard,
Elvin R Smith,
Eric R Holm,
Erica R Havely,
Erica R Woody,
Erik W Burrows,
Felix J Marrero,
Frank L Cordova,
Gary C Pecic,
Gerard T Schneider,
Gina M Scholze,
Hanna L Potter,
Holly L Miller,
Isabel Y Espinosa,
James P Stallings,
Jamie L Dion,
Janet Pulver,
Jennifer A Baker,
Jennifer A Robinson,
Jessica M Ector,
Jin M Kim,
John A Daubenspeck,
Ka L Wong,
Kamara Co,
Kathryn M Mogen,
Keith C Littrell,
Kenneth S Boehnen,
Khumo A Phake,
Kimberley A Hoefen,
Kristen E Szenderski,
Kristi B Panzer,
Larisa E Pavlick,
Larry Gehring,
Laura B Kennedy,
Lavender M Huskey,
Linda F Murphy,
Linda M Cheny,
Lucas B Leake,
Manuel A Moreno,
Marc A Jackson, Jr,
Margo Cl Jones,
Marie Bbuen Bigornia,
Mary C Wall,
Mary F Bodick,
Michael E Maselli,
Mikayla K Deardorff,
Nathan M Jornod,
Nayan J Patel,
Nicholas Fragedakis,
Oluwaseyi Ojinni,
Patricia A Brown,
Patricia A Maestas,
Paul J Teitell,
Randy V Bong,
Rebecca S Secrist,
Sean P Desbrow,
Sheila Alaghemand,
Shererk,
Siobhan A Gallagher,
Siobhan G Taylor,
State Agency,
Theressa B Smith,
Thomas V Anderson,
Timothy T Kapsala,
Vanessa R Muller,
Zachary L Miller,
Zachary P Wachlarowicz
Laura L Van Wagenen's Documents
Publish Date | Document Type | Title |
---|---|---|
January, 2018 | FDA 483 | Meadow Gold LLC - Form 483, 2018-01-12 |
Experience Redica Systems’ NEW investigator profiles and dashboards
Redica Systems customers get access to over 1,400 FDA Investigator profiles, containing powerful analysis like:
- Total inspections conducted
- 483 rate
- OAI rate
- Warning Letter rate
- Inspections by Industry, Scope, and Inspection Reason
- And much more
Investigator Profiles are not sold as on-demand documents. If you’d like to see one, fill out the form below to connect with our Sales Team and get it in your inbox as little as 24 hours.
![FDA Investigator Profile Icon](https://redica.com/document-store/images/InspectorProfile.png)
Talk to sales to access our investigator profiles
Loading...
Investigator Profiles Are Just the Tip of the Iceberg
Becoming a Redica Systems customer not only provides you with unlimited access to profiles similar to the one above for every current and former FDA Investigator, but also grants you access to:
Inspection Intelligence
- Pre-Approval Inspection (PAI) trends
- The ability to filter nearly any FDA enforcement action by GxP labels like GMP, GCP, etc.
- Latest 483s: see what the trends are across all FDA Investigators
- CFR Heatmap: Citations aggregated by Subpart by Year
Vendor Intelligence
- Full inspection histories for your vendors down to the specific site level
- All of the functionality mentioned above but isolated to just your vendors
Regulatory Intelligence
- Zero in on the trends for a specific agency/regulator (ex. FDA, MHRA, EMA, Health Canada)
- All the latest "Signals" from agencies around the world, segmented by Country, Type (ex. Guidance, Decree...), Category (ex. Rules/Regulations/Guidance, News, Reports...), Theme (ex. Cell and Gene Therapy, AI...), and more